Year |
Citation |
Score |
2020 |
Chen TH, Chen CC, Huang MH, Huang CH, Jan JT, Wu SC. Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine. Vaccines. 8. PMID 32455704 DOI: 10.3390/vaccines8020240 |
0.32 |
|
2019 |
Tang N, Lin SW, Chen TH, Jan JT, Wu HY, Wu SC. Highly Pathogenic Avian Influenza H5 Hemagglutinin Fused with the A Subunit of Type IIb Heat Labile Enterotoxin Elicited Protective Immunity and Neutralization by Intranasal Immunization in Mouse and Chicken Models. Vaccines. 7. PMID 31766677 DOI: 10.3390/vaccines7040193 |
0.32 |
|
2019 |
Cherng JH, Hsu YJ, Liu CC, Tang SH, Sartika D, Chang SJ, Fan GY, Wu ST, Meng E. Activities of Calcium-Related Ion Channels during the Formation of Kidney Stones in an Infection-Induced Urolithiasis Rat Model. American Journal of Physiology. Renal Physiology. PMID 31509008 DOI: 10.1152/ajprenal.00199.2019 |
0.32 |
|
2019 |
Chen TH, Liu WC, Chen IC, Liu CC, Huang MH, Jan JT, Wu SC. Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development. Vaccine. PMID 31383491 DOI: 10.1016/j.vaccine.2019.02.040 |
0.32 |
|
2019 |
Hong JY, Chen TH, Chen YJ, Liu CC, Jan JT, Wu SC. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development. Antiviral Research. PMID 30738089 DOI: 10.1016/j.antiviral.2019.02.004 |
0.32 |
|
2018 |
Hsu PK, Chen HS, Liu CC, Wu SC. Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. PMID 30430325 DOI: 10.1245/s10434-018-7060-y |
0.32 |
|
2018 |
Chen TH, Liu WC, Lin CY, Liu CC, Jan JT, Spearman M, Butler M, Wu SC. Glycan-masking hemagglutinin antigens from stable CHO cell clones for H5N1 avian influenza vaccine development. Biotechnology and Bioengineering. PMID 30080931 DOI: 10.1002/bit.26810 |
0.32 |
|
2018 |
Chang CK, Wu SR, Chen YC, Lee KJ, Chung NH, Lu YJ, Yu SL, Liu CC, Chow YH. Mutations in VP1 and 5'-UTR affect enterovirus 71 virulence. Scientific Reports. 8: 6688. PMID 29703921 DOI: 10.1038/s41598-018-25091-7 |
0.32 |
|
2017 |
Chen TH, Liu YY, Jan JT, Huang MH, Spearman M, Butler M, Wu SC. Recombinant hemagglutinin proteins formulated in a novel PELC/CpG adjuvant for H7N9 subunit vaccine development. Antiviral Research. 146: 213-220. PMID 28947234 DOI: 10.1016/j.antiviral.2017.09.014 |
0.32 |
|
2017 |
Liu CC, Wu SC, Wu SR, Lin HY, Guo MS, Yung-Chih Hu A, Chow YH, Chiang JR, Shieh DB, Chong P. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture. Vaccine. PMID 28274636 DOI: 10.1016/j.vaccine.2017.02.042 |
0.32 |
|
2016 |
Liu WC, Liu YY, Chen TH, Liu CC, Jan JT, Wu SC. Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design. Antiviral Research. PMID 27491439 DOI: 10.1016/j.antiviral.2016.07.021 |
0.32 |
|
2016 |
Liu WC, Jan JT, Huang YJ, Chen TH, Wu SC. Unmasking stem-specific neutralizing epitopes by abolishing N-linked glycosylation sites of influenza hemagglutinin proteins for vaccine design. Journal of Virology. PMID 27440889 DOI: 10.1128/JVI.00880-16 |
0.32 |
|
2016 |
Yang YT, Chow YH, Hsiao KN, Hu KC, Chiang JR, Wu SC, Chong P, Liu CC. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology. Antiviral Research. PMID 27387826 DOI: 10.1016/j.antiviral.2016.06.014 |
0.32 |
|
2016 |
Liu WC, Lin YL, Spearman M, Cheng PY, Butler M, Wu SC. Influenza Hemagglutinin Glycoproteins with Different N-glycan Patterns Activate Dendritic Cells in Vitro. Journal of Virology. PMID 27099319 DOI: 10.1128/JVI.00452-16 |
0.32 |
|
2015 |
Li TW, Cheng SF, Tseng YT, Yang YC, Liu WC, Wang SC, Chou MJ, Lin YJ, Wang Y, Hsiao PW, Wu SC, Chang DK. Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2). Archives of Virology. PMID 26446888 DOI: 10.1007/s00705-015-2625-6 |
0.32 |
|
2015 |
Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Journal of Virology. 89: 7224-34. PMID 25948745 DOI: 10.1128/JVI.00585-15 |
0.32 |
|
2015 |
Lai CH, Tang N, Jan JT, Huang MH, Lu CY, Chiang BL, Huang LM, Wu SC. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection. Vaccine. PMID 25858857 DOI: 10.1016/j.vaccine.2015.03.082 |
0.32 |
|
2014 |
Liu CC, Hwang CS, Yang WS, Tsai DC, Wu SH, Chou AH, Chow YH, Wu SC, Wang JR, Chiang JR, Huang CC, Pan CH, Chong P. Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques. Plos One. 9: e106756. PMID 25197967 DOI: 10.1371/journal.pone.0106756 |
0.32 |
|
2014 |
Lin SC, Liu WC, Jan JT, Wu SC. Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses. Plos One. 9: e92822. PMID 24671139 DOI: 10.1371/journal.pone.0092822 |
0.32 |
|
2013 |
Lin CW, Chang CY, Chen WL, Lin SC, Liao CC, Chang JY, Liu CC, Hu AY, Lu TC, Chou AH, Wu SC, Chong P, Huang MH. Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV. Human Vaccines & Immunotherapeutics. 9: 2378-85. PMID 23838466 DOI: 10.4161/hv.25639 |
0.32 |
|
2013 |
Lin SC, Liu WC, Lin YF, Huang YH, Liu JH, Wu SC. Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses. Biotechnology Journal. 8: 1315-22. PMID 23813782 DOI: 10.1002/biot.201300116 |
0.32 |
|
2013 |
Lin SC, Jan JT, Dionne B, Butler M, Huang MH, Wu CY, Wong CH, Wu SC. Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycans. Plos One. 8: e66719. PMID 23799128 DOI: 10.1371/journal.pone.0066719 |
0.32 |
|
2012 |
Chou AH, Liu CC, Chang JY, Lien SP, Guo MS, Tasi HP, Hsiao KN, Liu SJ, Sia C, Wu SC, Lee MS, Hsiao CH, Wang JR, Chow YH, Chong P. Immunological evaluation and comparison of different EV71 vaccine candidates. Clinical & Developmental Immunology. 2012: 831282. PMID 23008736 DOI: 10.1155/2012/831282 |
0.32 |
|
2012 |
Chong P, Hsieh SY, Liu CC, Chou AH, Chang JY, Wu SC, Liu SJ, Chow YH, Su IJ, Klein M. Production of EV71 vaccine candidates. Human Vaccines & Immunotherapeutics. 8: 1775-83. PMID 22992566 DOI: 10.4161/hv.21739 |
0.32 |
|
2011 |
Lin SC, Huang MH, Tsou PC, Huang LM, Chong P, Wu SC. Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. Plos One. 6: e20052. PMID 21655326 DOI: 10.1371/journal.pone.0020052 |
0.32 |
|
2011 |
Wei HJ, Chang W, Lin SC, Liu WC, Chang DK, Chong P, Wu SC. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines. Vaccine. 29: 7163-72. PMID 21651946 DOI: 10.1016/j.vaccine.2011.05.077 |
0.32 |
|
2010 |
Liu WC, Lin SC, Yu YL, Chu CL, Wu SC. Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses. Journal of Virology. 84: 12011-7. PMID 20844030 DOI: 10.1128/JVI.01316-10 |
0.32 |
|
2010 |
Liu CC, Liu JH, Wu SC, Yen CC, Chen WS, Tsai YC. A novel E1B-55kD-deleted oncolytic adenovirus carrying mutant KRAS-regulated hdm2 transgene exerts specific antitumor efficacy on colorectal cancer cells. Molecular Cancer Therapeutics. 9: 450-60. PMID 20124454 DOI: 10.1158/1535-7163.MCT-09-0704 |
0.32 |
|
2009 |
Wu SC. RNA interference technology to improve recombinant protein production in Chinese hamster ovary cells Biotechnology Advances. 27: 417-422. PMID 19289164 DOI: 10.1016/j.biotechadv.2009.03.002 |
0.32 |
|
2003 |
Wu SC, Yu CH, Lin CW, Chu IM. The domain III fragment of Japanese encephalitis virus envelope protein: Mouse immunogenicity and liposome adjuvanticity Vaccine. 21: 2516-2522. PMID 12744886 DOI: 10.1016/S0264-410X(03)00042-2 |
0.32 |
|
2003 |
Wu SC, Chu IM. Special issue on the 2002 Symposium of Young Asian Biochemical Engineers' Community (YABEC), Taipei, Taiwan Enzyme and Microbial Technology. 33: 331. DOI: 10.1016/S0141-0229(03)00164-9 |
0.32 |
|
1999 |
Wu SC. Influence of hydrodynamic shear stress on microcarrier-attached cell growth: Cell line dependency and surfactant protection Bioprocess Engineering. 21: 201-206. DOI: 10.1007/s004490050663 |
0.32 |
|
Show low-probability matches. |